Dr Andrew Osborne
Department of Clinical Neurosciences
Cambridge Centre for Brain Repair
My research interest lies in how stem cells offer neuroprotection to retinal ganglion cells with particular interest to how secreted factors prevent visual loss.
My project focuses on how platelet-derived growth factor (PDGF) can reduce retinal damage in human and animal models of glaucoma and its implications as a future therapy.
No collaborators listed
Associated News Items
Johnson TV, Dekorver NW, Levasseur VA, Osborne A, Tassoni A, Lorber B, Heller JP, Villasmil R, Bull ND, Martin KR, Tomarev SI (2014), “Identification of retinal ganglion cell neuroprotection conferred by platelet-derived growth factor through analysis of the mesenchymal stem cell secretome.” Brain 137(Pt 2):503-19 Details
Niyadurupola N, Sidaway P, Osborne A, Broadway DC, Sanderson J (2011), “The development of human organotypic retinal cultures (HORCs) to study retinal neurodegeneration.” Br J Ophthalmol 95(5):720-6 Details